Delivery Order SPE2DB24D3013-SPE2DB25FFGLG

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,943.82, is for the supply of Zolmitriptan 2.5 mg Orally Disintegrating Tablets (ODT) on a firm-fixed-price basis. The contract has an ultimate completion date of February 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,268.48 firm fixed-price delivery order covers the supply of 4,566,785,123 units of the medication Zolmitriptan 2.5 mg Orally Disintegrating Tablets. The contract has a period of performance through December 24, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,424.52 delivery order contract is for the supply of Zolmitriptan 2.5 mg tablets, a medication used to treat migraine headaches. The contract has a firm fixed price and a completion date of December 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,712.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of zolmitriptan 5 mg tablets and has a completion date of November 19, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $3,621.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,407,890 zolmitriptan 5 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,192,588 units of Zolmitriptan 5 mg tablets. The order, valued at $2,705.99, has a firm fixed-price contract type and an ultimate completion date of July 19, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded this contract as well as several Indefinite Delivery Contracts (IDCs) by various federal agencies,...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999. The award is for the supply of zolmitriptan 5 mg tablets to support federal healthcare programs. The total ceiling value of this specific delivery order is $1,076.94, with a firm fixed-price pricing type. The contract does not have a set-aside designation and is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,281.12, is for the delivery of 6 units of the prescription drug zolmitriptan 2.5 mg orally disintegrating tablets. The contract is a firm-fixed-price delivery order with a completion date of May 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is for the delivery of zolmitriptan 5 mg orally disintegrating tablets in unit dose packages. The contract has a ceiling value of $1,117.44 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite...
This federal contract award, identified as SPE2DB20D3101|SPE2DB23FRGQ1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,918.90 firm fixed-price delivery order is for the supply of Zolmitriptan 5 mg Orally Disintegrating Tablets, with a period of performance through March 30, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFGLG
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,465.79, is for the delivery of zolmitriptan 2.5 mg orally disintegrating tablets. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/20/25, 2:00 PM